Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $18.4850 (-1.02%) ($17.8200 - $19.2900) on Tue. Aug. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.16% (three month average) | RSI | 30 | Latest Price | $18.4850(-1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -3.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -2.08% in a week (0% probabilities). VIXM(-35%) VXX(-33%) UUP(-18%) DRIV(-4%) XLC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.08% (StdDev 4.16%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $8.16(-55.86%) | Resistance Level | $20.91 | 5 Day Moving Average | $19.95(-7.34%) | 10 Day Moving Average | $19.97(-7.44%) | 20 Day Moving Average | $20.91(-11.6%) | To recent high | -23.5% | To recent low | 10% | Market Cap | $2.341b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |